Literature DB >> 8590528

Peripheral vascular complications following coronary interventional procedures.

T K Nasser1, E R Mohler, R L Wilensky, D R Hathaway.   

Abstract

We report the incidence, diagnosis, prevention, and treatment of peripheral vascular complications following coronary interventional procedures as reviewed in the English-language literature. Peripheral vascular complications include hematomas, pseudoaneurysms, arteriovenous fistulae, acute arterial occlusions, cholesterol emboli, and infections that occur with an overall incidence of 1.5-9%. Major predictors of such complications following coronary interventional procedures include advanced age, repeat percutaneous transluminal coronary angioplasty, female gender, and peripheral vascular disease. Minor predictors include level of anticoagulation, use of thrombolytic agents, elevated creatinine levels, low platelet counts, longer periods of anticoagulation, and use of increased sheath size. Ultrasound-guided compression repair of pseudoaneurysms and arteriovenous fistulae are discussed, as are newer methods of treatment such as hemostatic puncture closure devices. Anticipation and early recognition of possible peripheral vascular complications in conjunction with careful attention to the optimal activated clotting time for sheath removal following coronary interventional procedures may translate into fewer vascular complications as well as into shorter and less costly hospital stays.

Entities:  

Mesh:

Year:  1995        PMID: 8590528     DOI: 10.1002/clc.4960181105

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  30 in total

1.  Mycotic aneurysm after percutaneous transluminal femoral artery angioplasty.

Authors:  T Qureshi; A B Hawrych; N F Hopkins
Journal:  J R Soc Med       Date:  1999-05       Impact factor: 5.344

Review 2.  Percutaneous coronary intervention in diabetics.

Authors:  Juhana Karha; Deepak L Bhatt
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  Radioembolization complicated by dissection of the common femoral artery.

Authors:  Sarah G Deitch; Ramona Gupta
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

4.  Safety and feasibility of a novel vascular closure device in neurointerventional procedures.

Authors:  Ammar Taha; Ellen K Walsh; Kathryn A Wright; Iftikhar Ahmed; Nucharin Supakul; Eric E Awwad; Juan G Tejada
Journal:  Interv Neuroradiol       Date:  2013-09-26       Impact factor: 1.610

5.  Safe and feasible immediate retransfer of patients to the referring hospital after acute coronary angiography and percutaneous coronary angioplasty for patients with acute coronary syndrome.

Authors:  Jack Gunnar Andersen; Nils-Einar Kløw; Odd Johansen
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-09

6.  Bleeding complications after contemporary pharmacoinvasive therapy for ST elevation myocardial infarction.

Authors:  Matthew J Gutierrez; Atul Aggarwal; Kristin Gilbert; Burton E Sobel; Harold L Dauerman
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

7.  Angio-Seal™ Evolution™ versus Manual Compression for Common Femoral Artery Puncture in Neurovascular Diagnostic Angiography : A Prospective, Non-Randomized Study.

Authors:  Joonho Chung; Dong Woo Lee; Ok Sim Kwon; Bum-Soo Kim; Yong Sam Shin
Journal:  J Korean Neurosurg Soc       Date:  2011-03-31

8.  Cholesterol emboli syndrome--uncommon or unrecognized?

Authors:  S P Bell; A Frankel; E A Brown
Journal:  J R Soc Med       Date:  1997-10       Impact factor: 5.344

9.  Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients at High Risk for Bleeding.

Authors:  Alexander Feldman; Khalid Suleiman; Limor Bushari; Malka Yahalom; Ehud Rozner; Nahum Adam Freedberg; Yoav Turgeman
Journal:  Int J Angiol       Date:  2014-12

10.  Ultrasound in evaluation of post-interventional femoral vein obstruction: a case report.

Authors:  Mai Tone Lønnebakken; Eva Gerdts; Jan Wirsching; Ole Martin Pedersen
Journal:  Cardiovasc Ultrasound       Date:  2009-03-26       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.